Jerry Lanchbury

Jerry Lanchbury serves on multiple scientific advisory boards, including positions at Galatea Bio Inc., Nucleus, GLX ANALYTIX, and Orchid, and holds the role of Entrepreneur in Residence at DigitalDx Ventures. Lanchbury has a background in leadership roles, notably as Chief Scientific Officer at Myriad Genetics, overseeing operational research and development in molecular diagnostics for nearly two decades. Additional experience includes executive positions at GKT School of Medicine, King's College London, and strategic advisory work at Gemini Genomics. Lanchbury earned a PhD in Human Population Genetics from Newcastle University and holds a BSc in Biology from Aston University.